Abstract P5-13-25: PIK3CA registry: A noninterventional, descriptive, retrospective cohort study of PIK3CA mutations in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)

Pathmanathan Rajadurai,Tatiana Semiglazova,Joanne W Chiu,Antoine Arnaud,Fadi El Karak,Sina Haftchenary,Jiwen Wu,Lyudmila Zhukova,Latonya Smith,Josef Jem Kitzen,Lakshmi Menon-Singh,Hamdy A Azim,Sudeep Gupta,Alinta Hegmane

doi:10.1158/1538-7445.sabcs21-p5-13-25

Abstract P5-13-25: PIK3CA registry: A noninterventional, descriptive, retrospective cohort study of PIK3CA mutations in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)

Pathmanathan Rajadurai, Tatiana Semiglazova + Show 12 more

https://doi.org/10.1158/1538-7445.sabcs21-p5-13-25

Copy DOI

Journal: American Journal of Cancer	Publication Date: Feb 15, 2022
Citations: 3

Affiliation: Subang Jaya Medical Centre, Queen Mary Hospital, Institut Sainte Catherine, Massachusetts General Hospital, Novartis (Canada), Tris Pharma (United States), Moscow Clinical Scientific Center, Albert Schweitzer Ziekenhuis, Cairo University, Tata Memorial Hospital, Riga East University Hospital

#PIK3CA Mut #Advanced Breast Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Abstract P5-13-25: <i>PIK3CA</i> registry: A noninterventional, descriptive, retrospective cohort study of <i>PIK3CA</i> mutations in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)

Full Text